Abstract
Background: Early palliative care is increasingly recognized as an important component of high-quality cancer care; however, the timing and extent of its integration vary across oncologic disciplines, including gastrointestinal (GI) oncology. Patients with GI malignancies frequently experience early symptom burden, complex treatment courses, and prognostic uncertainty, contributing to substantial supportive care needs over the disease trajectory.
Methods: This narrative review synthesizes evidence on early palliative care in gastrointestinal oncology from randomized controlled trials, systematic reviews, GI oncology–specific clinical guidelines, and observational and health services research. The objective was to characterize patterns of evidence, implementation approaches, and ethical considerations relevant to early integration in gastrointestinal oncology.
Results: Across heterogeneous study designs, early palliative care involvement is associated with improvements in quality of life, symptom control, and communication outcomes, without evidence of interference with disease-directed therapies. In GI oncology, particularly pancreatic cancer and hepatocellular carcinoma, unmet supportive care needs are consistently described. Diagnosis-anchored and needs-based referral approaches are discussed as alternatives to time-based models in settings of prognostic uncertainty. Evidence supporting home-based or hybrid palliative care models in GI oncology remains limited and context dependent.
Conclusion: Overall, the literature suggests that earlier integration of palliative care may be appropriate for selected patients with gastrointestinal malignancies. Given variability in symptom burden and clinical trajectories, time-based referral models may be insufficient in some settings, whereas needs-based and diagnosis-anchored approaches may offer flexible frameworks. Ethical considerations should be interpreted in light of patient preferences, feasibility, and health system capacity, rather than framed as universal mandates.
References
1. Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF, Epstein AS, Firn JI, Jones JA, Litzow MR, Lundquist D, Mardones MA, Nipp RD, Rabow MW, Rosa WE, Zimmermann C, Ferrell BR. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2024: 2336 [PMID: 38748941, https://doi.org/10.1200/JCO.24.00542]
2. Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017: 96 [PMID: 28034065, https://doi.org/10.1200/JCO.2016.70.1474]
3. World Health O. Palliative care. Geneva: 2020.
4. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011: 489 [PMID: 21296615, https://doi.org/10.1016/S1470-2045(10)70218-7]
5. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018: 17105 [PMID: 29345251, https://doi.org/10.1038/nrdp.2017.105]
6. Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014: 754 [PMID: 25291291, https://doi.org/10.1038/nrc3829]
7. Janberidze E, Hjermstad MJ, Haugen DF, Sigurdardottir KR, Lohre ET, Lie HC, Loge JH, Kaasa S, Knudsen AK, Euro I. How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature review. J Pain Symptom Manage. 2014: 678 [PMID: 24681108, https://doi.org/10.1016/j.jpainsymman.2013.11.013]
8. Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J, Choo SP, Cheow PC, Chotipanich C, Lim K, Lesmana LA, Manuaba TW, Yoong BK, Raj A, Law CS, Cua IHY, Lobo RR, Teh CSC, Kim YH, Jong YW, Han HS, Bae SH, Yoon HK, Lee RC, Hung CF, Peng CY, Liang PC, Bartlett A, Kok KYY, Thng CH, Low AS, Goh ASW, Tay KH, Lo RHG, Goh BKP, Ng DCE, Lekurwale G, Liew WM, Gebski V, Mak KSW, Soo KC, Asia-Pacific Hepatocellular Carcinoma Trials G. SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. J Clin Oncol. 2018: 1913 [PMID: 29498924, https://doi.org/10.1200/JCO.2017.76.0892]
9. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008: 629 [PMID: 18539529, https://doi.org/10.1016/S1470-2045(08)70153-0]
10. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017: 11 [PMID: 27637832, https://doi.org/10.1016/j.clnu.2016.07.015]
11. Gaertner J, Siemens W, Meerpohl JJ, Antes G, Meffert C, Xander C, Stock S, Mueller D, Schwarzer G, Becker G. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ. 2017: j2925 [PMID: 28676557, https://doi.org/10.1136/bmj.j2925]
12. Hui D, Hannon BL, Zimmermann C, Bruera E. Improving patient and caregiver outcomes in oncology: Team-based, timely, and targeted palliative care. CA Cancer J Clin. 2018: 356 [PMID: 30277572, https://doi.org/10.3322/caac.21490]
13. Maltoni M, Scarpi E, Dall'Agata M, Schiavon S, Biasini C, Codeca C, Broglia CM, Sansoni E, Bortolussi R, Garetto F, Fioretto L, Cattaneo MT, Giacobino A, Luzzani M, Luchena G, Alquati S, Quadrini S, Zagonel V, Cavanna L, Ferrari D, Pedrazzoli P, Frassineti GL, Galiano A, Casadei Gardini A, Monti M, Nanni O, Early Palliative Care Italian Study G. Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016: 110 [PMID: 27821313, https://doi.org/10.1016/j.ejca.2016.10.004]
14. Bojesson A, Brun E, Eberhard J, Segerlantz M. Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial. Br J Cancer. 2024: 729 [PMID: 38951699, https://doi.org/10.1038/s41416-024-02764-x]
15. Zorron Cheng Tao Pu L, Singh G, Rajadurai A, Terbah R, De Silva R, Vaughan R, Efthymiou M, Chandran S. Benefits of phone consultation for endoscopy-related clinics in the COVID-19 pandemic. J Gastroenterol Hepatol. 2021: 1064 [PMID: 33037824, https://doi.org/10.1111/jgh.15292]
16. Makela MJ, Gyllfors P, Valovirta E, Steffensen MA, Gronager PM, Savolainen J, Winther L. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis. Clin Ther. 2018: 574 [PMID: 29551533, https://doi.org/10.1016/j.clinthera.2018.02.012]
17. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000: 469 [PMID: 10678857, https://doi.org/10.1136/bmj.320.7233.469]
18. Hui D, Kim YJ, Park JC, Zhang Y, Strasser F, Cherny N, Kaasa S, Davis MP, Bruera E. Integration of oncology and palliative care: a systematic review. Oncologist. 2015: 77 [PMID: 25480826, https://doi.org/10.1634/theoncologist.2014-0312]
19. Kelley AS, Morrison RS. Palliative Care for the Seriously Ill. N Engl J Med. 2015: 747 [PMID: 26287850, https://doi.org/10.1056/NEJMra1404684]
20. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010: 733 [PMID: 20818875, https://doi.org/10.1056/NEJMoa1000678]
21. Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial. J Clin Oncol. 2015: 1438 [PMID: 25800768, https://doi.org/10.1200/JCO.2014.58.6362]
22. Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014: 1721 [PMID: 24559581, https://doi.org/10.1016/S0140-6736(13)62416-2]
23. Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017: CD011129 [PMID: 28603881, https://doi.org/10.1002/14651858.CD011129.pub2]
24. Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, Hoydich ZP, Ikejiani DZ, Klein-Fedyshin M, Zimmermann C, Morton SC, Arnold RM, Heller L, Schenker Y. Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis. JAMA. 2016: 2104 [PMID: 27893131, https://doi.org/10.1001/jama.2016.16840]
25. Sasaki K, Kanagal-Shamanna R, Montalban-Bravo G, Assi R, Jabbour E, Ravandi F, Kadia T, Pierce S, Takahashi K, Nogueras Gonzalez G, Patel K, Soltysiak KA, Cortes J, Kantarjian HM, Garcia-Manero G. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia. Cancer. 2020: 765 [PMID: 31742675, https://doi.org/10.1002/cncr.32566]
26. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008: 1665 [PMID: 18840840, https://doi.org/10.1001/jama.300.14.1665]
27. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010: 1203 [PMID: 20124172, https://doi.org/10.1200/JCO.2009.25.4672]
28. Aldridge MD, Hasselaar J, Garralda E, van der Eerden M, Stevenson D, McKendrick K, Centeno C, Meier DE. Education, implementation, and policy barriers to greater integration of palliative care: A literature review. Palliat Med. 2016: 224 [PMID: 26405109, https://doi.org/10.1177/0269216315606645]
29. Beauchamp T, Childress J. Principles of Biomedical Ethics: Marking Its Fortieth Anniversary. Am J Bioeth. 2019: 9 [PMID: 31647760, https://doi.org/10.1080/15265161.2019.1665402]
30. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF, Jr., Lynn J, Phillips RS. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998: 1709 [PMID: 9624023, https://doi.org/10.1001/jama.279.21.1709]
31. Kavalieratos D, Kamal AH, Abernethy AP, Biddle AK, Carey TS, Dev S, Reeve BB, Weinberger M. Comparing unmet needs between community-based palliative care patients with heart failure and patients with cancer. J Palliat Med. 2014: 475 [PMID: 24588568, https://doi.org/10.1089/jpm.2013.0526]
32. Roberts ET, Chernew ME, McWilliams JM. Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices. Health Aff (Millwood). 2017: 141 [PMID: 28069857, https://doi.org/10.1377/hlthaff.2016.0479]
33. Martins SS, Sampson L, Cerda M, Galea S. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. Am J Public Health. 2015: e29 [PMID: 26451760, https://doi.org/10.2105/AJPH.2015.302843]
34. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, Meier DE, Palliative Care Leadership Centers' Outcomes G. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med. 2008: 1783 [PMID: 18779466, https://doi.org/10.1001/archinte.168.16.1783]
35. May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, Smith TJ, Morrison RS. Cost analysis of a prospective multi-site cohort study of palliative care consultation teams for adults with advanced cancer: Where do cost-savings come from? Palliat Med. 2017: 378 [PMID: 28156192, https://doi.org/10.1177/0269216317690098]
36. Brumley R, Enguidanos S, Jamison P, Seitz R, Morgenstern N, Saito S, McIlwane J, Hillary K, Gonzalez J. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc. 2007: 993 [PMID: 17608870, https://doi.org/10.1111/j.1532-5415.2007.01234.x]
37. Smith TJ, Coyne P, Cassel B, Penberthy L, Hopson A, Hager MA. A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med. 2003: 699 [PMID: 14622449, https://doi.org/10.1089/109662103322515202]
38. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003: 1907 [PMID: 14667750, https://doi.org/10.1016/S0140-6736(03)14964-1]
39. Schenker Y, Crowley-Matoka M, Dohan D, Rabow MW, Smith CB, White DB, Chu E, Tiver GA, Einhorn S, Arnold RM. Oncologist factors that influence referrals to subspecialty palliative care clinics. J Oncol Pract. 2014: e37 [PMID: 24301842, https://doi.org/10.1200/JOP.2013.001130]
40. Erratum. Journal of the National Comprehensive Cancer Network. 2023: https://doi.org/10.6004/jnccn.2023.0024]
41. Nguyen AP. How palliative care transformed my perspective of medicine. J Palliat Med. 2011: 244 [PMID: 21314579, https://doi.org/10.1089/jpm.2010.0351]
42. Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med. 2013: 1173 [PMID: 23465068, https://doi.org/10.1056/NEJMp1215620]
43. Gomes B, Calanzani N, Higginson IJ. Reversal of the British trends in place of death: time series analysis 2004-2010. Palliat Med. 2012: 102 [PMID: 22258367, https://doi.org/10.1177/0269216311432329]
44. Calton BA, Rabow MW, Branagan L, Dionne-Odom JN, Parker Oliver D, Bakitas MA, Fratkin MD, Lustbader D, Jones CA, Ritchie CS. Top Ten Tips Palliative Care Clinicians Should Know About Telepalliative Care. J Palliat Med. 2019: 981 [PMID: 31237467, https://doi.org/10.1089/jpm.2019.0278]
45. El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol. 2011: 87 [PMID: 21702398, https://doi.org/10.1016/j.suponc.2011.03.003]
46. Raizman N. Happy genes. The Lancet. 2010: https://doi.org/10.1016/s0140-6736(10)60331-5]
47. Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, Canin B, Cohen HJ, Holmes HM, Hopkins JO, Janelsins MC, Khorana AA, Klepin HD, Lichtman SM, Mustian KM, Tew WP, Hurria A. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018: 2326 [PMID: 29782209, https://doi.org/10.1200/JCO.2018.78.8687]
48. Williams GR, Deal AM, Muss HB, Weinberg MS, Sanoff HK, Guerard EJ, Nyrop KA, Pergolotti M, Shachar SS. Frailty and skeletal muscle in older adults with cancer. J Geriatr Oncol. 2018: 68 [PMID: 28844849, https://doi.org/10.1016/j.jgo.2017.08.002]
49. Hui D, Bruera E. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016: 159 [PMID: 26598947, https://doi.org/10.1038/nrclinonc.2015.201]

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Abdullah Alabbasi, Muhanad Alzahrani

